Previous work conducted by the present authors has indicated that MSCs, which have been modified to overexpress BDNF, which, in turn, is downregulated in the brains of the HD patients, can ameliorate deficits in a rodent model of HD [7]. Here, BDNF is linked to Huntington disease.